HK1135107A1 - Method of reducing alpha, beta- unsaturated ketones in opioid compositions - Google Patents

Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Info

Publication number
HK1135107A1
HK1135107A1 HK10103566.6A HK10103566A HK1135107A1 HK 1135107 A1 HK1135107 A1 HK 1135107A1 HK 10103566 A HK10103566 A HK 10103566A HK 1135107 A1 HK1135107 A1 HK 1135107A1
Authority
HK
Hong Kong
Prior art keywords
beta
unsaturated ketones
reducing alpha
opioid compositions
reducing
Prior art date
Application number
HK10103566.6A
Other languages
English (en)
Inventor
Robert Joe Kupper
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of HK1135107A1 publication Critical patent/HK1135107A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK10103566.6A 2005-03-04 2010-04-13 Method of reducing alpha, beta- unsaturated ketones in opioid compositions HK1135107A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65879105P 2005-03-04 2005-03-04

Publications (1)

Publication Number Publication Date
HK1135107A1 true HK1135107A1 (en) 2010-05-28

Family

ID=36301669

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08102671.4A HK1111695A1 (en) 2005-03-04 2008-03-06 Method of reducing alpha, beta- unsaturated ketones in opioid compositions
HK10103566.6A HK1135107A1 (en) 2005-03-04 2010-04-13 Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK08102671.4A HK1111695A1 (en) 2005-03-04 2008-03-06 Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Country Status (19)

Country Link
US (1) US7939543B2 (xx)
EP (2) EP2112153B1 (xx)
JP (1) JP5314894B2 (xx)
KR (1) KR100941761B1 (xx)
CN (1) CN101133062B (xx)
AT (2) ATE487722T1 (xx)
CA (1) CA2598774C (xx)
CY (2) CY1109262T1 (xx)
DE (2) DE602006018208D1 (xx)
DK (2) DK2112153T3 (xx)
ES (2) ES2355870T3 (xx)
HK (2) HK1111695A1 (xx)
HR (2) HRP20090387T1 (xx)
ME (2) ME01184B (xx)
PL (2) PL1861405T3 (xx)
PT (2) PT2112153E (xx)
RS (2) RS51131B (xx)
SI (2) SI2112153T1 (xx)
WO (1) WO2006094672A1 (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
ES2407143T3 (es) * 2003-08-06 2013-06-11 Grünenthal GmbH Forma de dosificación protegida contra un posible abuso
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
MX2008010921A (es) 2006-03-02 2008-09-03 Mallinckrodt Inc Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
AU2007329451B2 (en) 2006-12-04 2012-08-30 Noramco, Llc Process for reducing impurities in oxycodone base
US7906647B2 (en) 2006-12-04 2011-03-15 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5373764B2 (ja) * 2007-04-16 2013-12-18 マリンクロッド エルエルシー 触媒性水素転移反応を使用する新規なオピエート還元
FR2923484B1 (fr) 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
CA2720108C (en) * 2008-03-11 2016-06-07 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) * 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
BR112012001244A2 (pt) 2009-07-22 2020-12-08 Gruünenthal Gmbh Forma de dosagem resitente à adulteração, seu processo de produção, e embalagem contendo tal forma
WO2011009602A1 (en) * 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
WO2011026125A2 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2377866B1 (en) 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
CA2802294C (en) 2010-06-11 2016-05-10 Rhodes Technologies Process for n-dealkylation of tertiary amines
AR082862A1 (es) 2010-09-02 2013-01-16 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
PT2736497T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
ES2692944T3 (es) 2012-04-18 2018-12-05 Grünenthal GmbH Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP2970320B1 (en) * 2013-03-15 2020-10-28 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
EP3166948A1 (en) 2014-07-09 2017-05-17 Rhodes Technologies Inc. Reduction of alpha, beta-unsaturated ketone levels in morphinan derivative compositions
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812312A (en) * 1971-11-15 1974-05-21 Chrysler Corp Impact velocity sensor switch with linearly movable controller
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TWI483944B (zh) * 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝

Also Published As

Publication number Publication date
SI2112153T1 (sl) 2011-02-28
JP5314894B2 (ja) 2013-10-16
EP1861405A1 (en) 2007-12-05
ME01594B (me) 2014-09-20
DE602006018208D1 (de) 2010-12-23
WO2006094672A1 (en) 2006-09-14
EP2112153B1 (en) 2010-11-10
RS51131B (sr) 2010-10-31
KR100941761B1 (ko) 2010-02-11
HRP20090387T1 (en) 2009-08-31
CN101133062B (zh) 2014-08-06
CY1111241T1 (el) 2015-06-11
ME01184B (me) 2013-03-20
EP1861405B1 (en) 2009-04-29
DK1861405T3 (da) 2009-07-20
ATE430153T1 (de) 2009-05-15
US7939543B2 (en) 2011-05-10
PT1861405E (pt) 2009-07-27
EP2112153A1 (en) 2009-10-28
SI1861405T1 (sl) 2009-10-31
HRP20110078T1 (hr) 2011-03-31
PT2112153E (pt) 2010-12-17
DE602006006558D1 (de) 2009-06-10
CA2598774A1 (en) 2006-09-14
ES2326491T3 (es) 2009-10-13
ES2355870T3 (es) 2011-03-31
KR20070108931A (ko) 2007-11-13
CA2598774C (en) 2010-12-21
HK1111695A1 (en) 2008-08-15
US20080132702A1 (en) 2008-06-05
ATE487722T1 (de) 2010-11-15
JP2008531626A (ja) 2008-08-14
CY1109262T1 (el) 2014-07-02
DK2112153T3 (da) 2011-02-14
CN101133062A (zh) 2008-02-27
PL2112153T3 (pl) 2011-04-29
PL1861405T3 (pl) 2009-10-30
RS51568B (en) 2011-08-31

Similar Documents

Publication Publication Date Title
HK1135107A1 (en) Method of reducing alpha, beta- unsaturated ketones in opioid compositions
MX2008010921A (es) Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
MA32301B1 (fr) 1-aryl-3-amino-alcoxypyrazoles comme ligands de sigma augmentant l'effet analgesique d'opioides et attenuant la dependance a ceux-ci
TW200736256A (en) Process for the preparation of substituted heterocycles
EA201100748A1 (ru) Пиразиновые соединения в качестве ингибиторов фосфодиэстеразы 10
WO2008013840A3 (en) Erastin analogs and uses thereof
NZ602862A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
EP1783166A4 (en) RESIN COMPOSITION AND PROCESS FOR PRODUCING LAMINATE USING THE SAME
WO2011060304A3 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
MX2010008899A (es) Procedimiento para la sintesis regioselectiva de derivados de acido 1-alquil-3-haloalquil-pirazol-4-carboxilico.
MY150082A (en) Trans-clomiphene for metabolic syndrome
MX2011008885A (es) Composiciones, sintesis y metodos para usar derivados de arilpiperazina.
WO2011060297A3 (en) Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions
DK2044067T3 (da) Fremgangsmåde til fremstilling af 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octanbromid
UA96994C2 (ru) Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии
ME01172B (me) (2r,4ar,10br)-6-(2,6-dimetoksipiridin-3-il)-9-etoksi-8-metoksi-1,2,3,4,4a,10b-heksahidrofenantridin-2-ol, hci so
WO2009154993A8 (en) Compositions, synthesis, and methods of using piperazine based antipsychotic agents
MX2011006845A (es) Inhibidores de glyt1 biciclicos 3.1.0 y metodos para elaboracion y utilizacion de los mismos.
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
ATE511760T1 (de) Nuss-stückchen enthaltendes kaugummi
EP2305803A4 (en) THERMOSTABLE 1,5-ANHYDROGLUCITOL DEHYDROGENASE AND METHOD OF MEASURING 1,5-ANHYDROGLUCITOL USING THE SAME
WO2009112709A3 (fr) Nouveau procede pour la preparation d'extraits de ginkgo biloba
WO2008011161A3 (en) Dermal anesthetic compounds
MX2009003200A (es) Procedimiento para la preparacion de pradofloxacino.